The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance
Open accessAbstract
The genome diversity of RNA viruses allows for rapid adaptation to a wide variety of adverse conditions. Accordingly, viruses can escape inhibition by most antiviral compounds targeting either viral or host factors. Here we exploited the capacity of RNA viruses for rapid adaptation to explore the evolutionary constraints of chaperone-mediated protein folding. We hypothesized that inhibiting a host molecular chaperone required for folding of a viral protein would force the virus to evolve an alternate folding strategy. We identified the chaperone Hsp90 as an essential factor for folding and maturation of picornavirus capsid proteins. Pharmacological inhibition of Hsp90 impaired the replication of poliovirus, rhinovirus, and coxsackievirus in cell culture. Strikingly, anti-Hsp90 treatment did not yield drug-resistant viruses, suggesting that the complexity of capsid folding precludes the emergence of alternate folding pathways. These results reveal tight evolutionary constraints on chaperone-mediated protein folding, which may be exploited for viral inhibition in vivo. Indeed, Hsp90 inhibitors drastically reduced poliovirus replication in infected animals without the emergence of drug-resistant escape mutants. We propose that targeting folding of viral proteins may provide a general antiviral strategy that is refractory to development of drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HSP90 and the chaperoning of cancer
Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502
RNA VIRUS MUTATIONS AND FITNESS FOR SURVIVAL
Domingo, E., & Holland, J. J. (1997) · Annual Review of Microbiology · doi:10.1146/annurev.micro.51.1.151 · Cited by 1,514
Pratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
Kamal, A., Thao, L., Sensintaffar, J., Zhang, L., Boehm, M. F., Fritz, L. C., & Burrows, F. J. (2003) · Nature · doi:10.1038/nature01913 · Cited by 1,387
Folding of Newly Translated Proteins In Vivo: The Role of Molecular Chaperones
Frydman, J. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.603 · Cited by 1,173
Self-citationVignuzzi, M., Stone, J. K., Arnold, J. J., Cameron, C. E., & Andino, R. (2006) · Nature · doi:10.1038/nature04388 · Cited by 1,116
Self-citationPathways of chaperone-mediated protein folding in the cytosol
Young, J. C., Agashe, V. R., Siegers, K., & Hartl, F. U. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1492 · Cited by 1,105
Crystal structure of an Hsp90–nucleotide–p23/Sba1 closed chaperone complex
Ali, M. M. U., Roe, S. M., Vaughan, C. K., Meyer, P., Panaretou, B., Piper, P. W., Prodromou, C., & Pearl, L. H. (2006) · Nature · doi:10.1038/nature04716 · Cited by 962
Young, J. C., Moarefi, I., & Hartl, F. U. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200104079 · Cited by 822
Heat-shock protein 90, a chaperone for folding and regulation
Picard, D. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/pl00012491 · Cited by 796
Proteome-wide Analysis of Chaperonin-Dependent Protein Folding in Escherichia coli
Kerner, M. J., Naylor, D. J., Ishihama, Y., Maier, T., Chang, H.-C., Stines, A. P., Georgopoulos, C., Frishman, D., Hayer-Hartl, M., Mann, M., et al. (2005) · Cell · doi:10.1016/j.cell.2005.05.028 · Cited by 659
Borkovich, K. A., Farrelly, F. W., Finkelstein, D. B., Taulien, J., & Lindquist, S. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.9.3919 · Cited by 641
Short interfering RNA confers intracellular antiviral immunity in human cells
Gitlin, L., Karelsky, S., & Andino, R. (2002) · Nature · doi:10.1038/nature00873 · Cited by 608
Self-citationHsp70 and Hsp90—a relay team for protein folding
Wegele, H., Müller, L., & Buchner, J. (2004) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0021-1 · Cited by 605
Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′-end of viral RNA.
Andino, R., Rieckhof, G. E., Achacoso, P. L., & Baltimore, D. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06032.x · Cited by 494
Self-citationPfeiffer, J. K., & Kirkegaard, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1232294100 · Cited by 404
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration
Waza, M., Adachi, H., Katsuno, M., Minamiyama, M., Sang, C., Tanaka, F., Inukai, A., Doyu, M., & Sobue, G. (2005) · Nature Medicine · doi:10.1038/nm1298 · Cited by 395
Poliovirus Cell Entry: Common Structural Themes in Viral Cell Entry Pathways
Hogle, J. M. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160757 · Cited by 352
Hu, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.1.59 · Cited by 312
Structure and Functional Relationships of Hsp90
Prodromou, C., & Pearl, L. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481877 · Cited by 261
Klump, W. M., Bergmann, I., Müller, B. C., Ameis, D., & Kandolf, R. (1990) · Journal of Virology · doi:10.1128/jvi.64.4.1573-1583.1990 · Cited by 253
Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90
Okamoto, T., Nishimura, Y., Ichimura, T., Suzuki, K., Miyamura, T., Suzuki, T., Moriishi, K., & Matsuura, Y. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601367 · Cited by 241
Recruitment of Hsp70 chaperones: a crucial part of viral survival strategies
Mayer, M. P. (2004) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-004-0025-5 · Cited by 221
Basavappa, R., Filman, D. J., Syed, R., Flore, O., Icenogle, J. P., & Hogle, J. M. (1994) · Protein Science · doi:10.1002/pro.5560031005 · Cited by 209
The Distribution of Rates of Spontaneous Mutation over Viruses, Prokaryotes, and Eukaryotes
DRAKE, J. W. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08870.x · Cited by 204
Inhibition of poliovirus RNA synthesis by brefeldin A
Maynell, L. A., Kirkegaard, K., & Klymkowsky, M. W. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.1985-1994.1992 · Cited by 180
Rho-modifying C3-like ADP-ribosyltransferases
Aktories, K., Wilde, C., & Vogelsgesang, M. (2004) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-004-0034-4 · Cited by 178
Poliovirus Requires a Precise 5′ End for Efficient Positive-Strand RNA Synthesis
Herold, J., & Andino, R. (2000) · Journal of Virology · doi:10.1128/jvi.74.14.6394-6400.2000 · Cited by 149
Self-citationMechanisms of genetic robustness in RNA viruses
Elena, S. F., Carrasco, P., Daròs, J., & Sanjuán, R. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400636 · Cited by 149
Burch, A. D., & Weller, S. K. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10740-10749.2005 · Cited by 145
Haas, A. L., & Rose, I. A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6845 · Cited by 140
Sarafianos, S. G., Das, K., Hughes, S. H., & Arnold, E. (2004) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2004.10.013 · Cited by 135
Functional Specificity of Co-Chaperone Interactions with Hsp90 Client Proteins
Riggs, D. L., Cox, M. B., Cheung‐Flynn, J., Prapapanich, V., Carrigan, P. E., & Smith, D. F. (2004) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230490892513 · Cited by 131
Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses
Crowder, S. M., & Kirkegaard, K. (2005) · Nature Genetics · doi:10.1038/ng1583 · Cited by 130
Heat Shock Protein 90 Inhibitors. A Text Book Example of Medicinal Chemistry?
Janin, Y. L. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050759r · Cited by 127
Folding of Viral Envelope Glycoproteins in the Endoplasmic Reticulum
Braakman, I., & van Anken, E. (2000) · Traffic · doi:10.1034/j.1600-0854.2000.010702.x · Cited by 107
Aberham, C., Weber, S., & Phares, W. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3536-3544.1996 · Cited by 102
Kampmueller, K. M., & Miller, D. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.6827-6837.2005 · Cited by 96
Hu, J., & Anselmo, D. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11447-11455.2000 · Cited by 95
Molecular Chaperone Hsp90 Is Important for Vaccinia Virus Growth in Cells
Hung, J., Chung, C.-S., & Chang, W. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1379-1390.2002 · Cited by 95
Brefeldin A Inhibits Cell-Free, De Novo Synthesis of Poliovirus
Cuconati, A., Molla, A., & Wimmer, E. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6456-6464.1998 · Cited by 85
Pillay, D., & Zambon, M. (1998) · BMJ · doi:10.1136/bmj.317.7159.660 · Cited by 83
Rapid Development of Drug-Resistant Mutants of Poliovirus
Melnick, J. L., Crowther, D., & Barrera-Oro, J. G. (1961) · Science · doi:10.1126/science.134.3478.557 · Cited by 79
Crotty, S., Hix, L. M., Sigal, L. J., & Andino, R. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-7-1707 · Cited by 74
Self-citationLi, Y., Tao, P., Liu, Y.-Z., & Jiang, J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.867-872.2004 · Cited by 73
Bucci, M., Roviezzo, F., Cicala, C., Sessa, W. C., & Cirino, G. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703549 · Cited by 67
Type D Retrovirus Gag Polyprotein Interacts with the Cytosolic Chaperonin TRiC
Hong, S., Choi, G., Park, S., Chung, A., Hunter, E., & Rhee, S. S. (2001) · Journal of Virology · doi:10.1128/jvi.75.6.2526-2534.2001 · Cited by 67
Ansardi, D. C., Porter, D. C., & Morrow, C. D. (1991) · Journal of Virology · doi:10.1128/jvi.65.4.2088-2092.1991 · Cited by 64
Crotty, S., Saleh, M., Gitlin, L., Beske, O. E., & Andino, R. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3378-3386.2004 · Cited by 54
Self-citationBasha, W., Kitagawa, R., Uhara, M., Imazu, H., 上地幸平, & Tanaka, J. (2005) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020501600206 · Cited by 49
HSP90: A Rising Star on the Horizon of Anticancer Targets
Whitesell, L. J., & Dai, C. (2005) · Future Oncology · doi:10.2217/14796694.1.4.529 · Cited by 40
Murata, T., Goshima, F., Koshizuka, T., Takakuwa, H., & Nishiyama, Y. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.1039-1043.2001 · Cited by 21
Cited by
Molecular chaperones in protein folding and proteostasis
Hartl, F. U., Bracher, A., & Hayer-Hartl, M. (2011) · Nature · doi:10.1038/nature10317 · Cited by 3,381
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
Hu, C., Yang, J., Qi, Z., Wu, H., Wang, B., Zou, F., Mei, H., Liu, J., Wang, W., & Liu, Q. (2022) · MedComm · doi:10.1002/mco2.161 · Cited by 779
Wandinger, S. K., Richter, K., & Buchner, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800007200 · Cited by 546
Metadata
- Authors
- Geller, R., Vignuzzi, M., Andino, R., & Frydman, J.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2007-01-15
- Volume
- 21
- Issue
- 2
- Pages
- 195-205
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2102253488
- Cited by
- 263
- References
- 52
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.